IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Trump campaign asks: Are you better off now than you were four years ago?

    03:40
  • ‘COVID stole our optimism’: Reminding Americans how bad things were four years ago

    09:48
  • 'Tell Me When It's Over' looks at lessons learned from the Covid-19 pandemic

    06:08
  • What the DeSantis campaign cost: 87,000 lives, $150 million and Ron's dignity

    07:35
  • 'The Big Fail': Learning from the COVID-19 pandemic

    10:45
  • ‘They’re obsessed’: Dr. Fauci on death threats, 'lab leak,' and vaccine safety

    27:57
  • Preparation for the next pandemic relies on persuasion, says author

    07:24
  • Controversy over Florida's Covid booster guidance

    03:02
  • FDA approves new Covid booster: What you need to know

    05:55
  • FDA could greenlight new Covid boosters, but they won't be free for everyone

    01:24
  • The dangers of RFK Jr. using antisemitic tropes

    07:52
  • Trump-appointed judge rules against Biden admin in Facebook censorship case

    06:36
  • Two Richmond schools extend year to tackle COVID-19 learning loss

    08:01
  • New report shows how hundreds of billions in COVID-19 aid vanished

    04:58
  • RFK Jr's campaign of conspiracies: 'The leader of everybody’s brain worms'

    08:36
  • ‘Disastrous position:’ The DeSantis bid to be the anti-vaccine candidate

    08:51
  • The truth about DeSantis’ awful record on covid

    23:00
  • Hayes: ‘Deranged’ GOP debt plan would put these items on the chopping block

    04:33

Bright spot in global Covid fight: Merck will share formula for antiviral Covid pill

04:25

Rachel Maddow shares the encouraging news that American company Merck has agreed to allow its inexpensive Covid treatment pill, which is seen as being on track to approval soon, to be manufactured by other companies around the world, including in developing nations where vaccine is scarce.